Stock Monitor: Cardiovascular Systems Post Earnings Reporting
LONDON, UK / ACCESSWIRE / February 09, 2018 / Active-Investors.com has just released a free earnings report on Align Technology, Inc. (NASDAQ: ALGN). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ALGN. The Company reported its fourth quarter fiscal 2017 and full fiscal year 2017 operating and financial results on January 30, 2018. The maker of the Invisalign tooth-straightening system outperformed top- and bottom-line estimates, and provided guidance for the upcoming quarter. Register today and get access to over 1000 Free Research Reports by joining our site below:
Active-Investors.com is currently working on the research report for Cardiovascular Systems, Inc. (NASDAQ: CSII), which also belongs to the Healthcare sector as the Company Align Technology. Do not miss out and become a member today for free to access this upcoming report at:
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Align Technology most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
Earnings Highlights and Summary
For the quarter ended December 31, 2017, Align Technology's revenues surged 43.7% to a record $421.3 million compared to $293.3 million in Q4 2016. The Company's revenue numbers topped analysts' estimates of $395.5 million.
For the full year FY17, Align Technology's revenues advanced 36.4% to $1.47 billion on a y-o-y basis compared to $1.08 billion in FY16.
During Q4 2017, Align Technology delivered a record operating income of $109.61 million, up 60.3% compared to $68.37 million in Q4 2016.
Align Technology reported a net income of $10.3 million, or $0.13 per diluted share, for Q4 2017, which included an $86.6 million tax expense, or $1.06 per diluted share negative impact due to the new US Tax Cut and Jobs Act (TCJA), comprised of a $10.0 million non-cash write-down of the Company's deferred tax assets and a mandatory deemed repatriation tax of $76.6 million. The Company reported earnings of $47.6 million, or $0.59 per diluted share, in Q4 2016. Align Technology's earnings on an adjusted basis totaled $1.19 per share, beating Wall Street's estimates of $0.96 per share.
For FY17, Align Technology's net profit was $231.4 million, or $2.83 per diluted share, including a $1.06 per diluted share negative impact due to the TCJA. The Company had reported net earnings of $189.7 million, or $2.33 per diluted share, for FY16.
During Q4 2017, Align Technology's Invisalign case shipments surged 34.2% to 255,000 on a y-o-y basis compared to 236,100 in Q4 2016. The segment's North America and International case shipments jumped 24.2% and 52.3% on a y-o-y basis, respectively. For Q4 2017, Invisalign cases for teenage patients were 63,500; up 44.1% compared to the year ago same period. The Company's scanner and services revenues surged 37.0% to $57.1 million on a y-o-y basis in Q4 2017.
For FY17, Align Technology reported record Invisalign revenues of $1.3 billion, up 34.1% on a y-o-y basis, with Invisalign case shipments of 931,045; up 31.4% versus 708,500 in FY16. For FY17, the Company's Invisalign cases for teenage patients were 237,500; up 40.4% on a y-o-y basis.
As of December 31, 2017, Align Technology had cash, cash equivalents, and marketable securities of $761.5 million compared to $700.0 million as of December 31, 2016. During Q4 2017, the Company repurchased approximately 0.2 million shares of stock for $50.0 million under the April 2016 Repurchase Program. Align Technology had $200.0 million remaining available for repurchases under the existing stock repurchase authorization.
For the first quarter of 2018 (Q1 2018), Align Technology is forecasting net revenues to be in the range of $400 million to $410 million, up approximately 29% to 32% on a y-o-y basis. The Company is expecting Invisalign case shipments to be in the band of 264,000 to 269,000 for Q1 2018, up approximately 27% to 29% over the year ago corresponding period.
For Q1 2018, Align Technology is projecting diluted earnings per share to be in the range of $0.94 to $0.98.
Stock Performance Snapshot
February 08, 2018 - At Thursday's closing bell, Align Technology's stock declined 5.81%, ending the trading session at $220.71.
Volume traded for the day: 1.92 million shares, which was above the 3-month average volume of 1.23 million shares.
Stock performance in the previous six-month period – up 25.57%; and past twelve-month period – up 134.37%
After yesterday's close, Align Technology's market cap was at $17.57 billion.
Price to Earnings (P/E) ratio was at 77.88.
The stock is part of the Healthcare sector, categorized under the Medical Appliances & Equipment industry.
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.